RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BLAIS N
Collezione AOU San Luigi di Orbassano

Items : 4

Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary. in Future oncology (London, England) / Future Oncol. 2025 Mar 24:1-12. doi: 10.1080/14796694.2025.2474789.

2025
AOU San Luigi di Orbassano

de Langen AJ; Johnson ML; Mazieres J; Dingemans AC; Mountzios G; Pless M; Wolf J; Schuler M; Lena H; Skoulidis F; Yoneshima Y; Kim SW; Linardou H; Novello S; van der Wekken AJ; Chen Y; Peters S; Felip E; Solomon BJ; Ramalingam SS; Dooms C; Lindsay CR; Ferreira CG; Blais N; Obiozor CC; Wang Y; Mehta B; Varrieur T; Ngarmchamnanrith G; et alii...

Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Oct;196:107921. doi: 10.1016/j.lungcan.2024.107921. Epub 2024 Aug 6.

2024
AOU San Luigi di Orbassano

Waterhouse DM; Rothschild S; Dooms C; Mennecier B; Bozorgmehr F; Majem M; van den Heuvel MH; Linardou H; Chul Cho B; Roberts-Thomson R; Tanaka K; Blais N; Schvartsman G; Holmskov Hansen K; Chmielewska I; Forster MD; Giannopoulou C; Stollenwerk B; Obiozor CC; Wang Y; Novello S;

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial. in Lancet (London, England) / Lancet. 2023 Mar 4;401(10378):733-746. doi: 10.1016/S0140-6736(23)00221-0. Epub 2023 Feb 7.

2023
AOU San Luigi di Orbassano

Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ?1% by the USA Food and Drug Administration. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Nov 1;30(11):1686-1688. doi: 10.1093/annonc/mdz295.

2019
AOU San Luigi di Orbassano

Mountzios G; Remon J; Novello S; Blais N; Califano R; Cufer T; Dingemans AM; Liu SV; Peled N; Pennell NA; Reck M; Rolfo C; Tan D; Vansteenkiste J; West H; Besse B;